Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07523750 · ClinicalTrials.gov registry record · NA
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
A NA study, sponsored by Biosense Webster.
- Recruiting
- Registry status
- NA
- Development phase
- 466
- Enrollment target
NCT07523750 is a NA study that is actively recruiting participants, run by Biosense Webster. The registered enrollment target is 466 participants.
The verdict
NCT07523750, a NA study, is actively recruiting participants, sponsored by Biosense Webster.
- RECRUITING
- Registry status
- NA
- Development phase
- 466 participants
- Enrollment target
Study Summary
The purpose of this study is to assess how safe VARIPULSE pulsed field ablation (PFA) catheter is and how well it works compared to food and drug administration (FDA) approved FARAWAVE PFA catheter in participants with symptomatic persistent atrial fibrillation (PsAF; continuous irregular, rapid heartbeat that lasts over 7 days and doesn't stop on its own).
Interventions
- DEVICE VARIPULSE Catheter
- DEVICE FARAWAVE Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 466 participants |
| Start Date | 2026-04-02 |
| Est. Completion | 2028-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07523750
The ClinicalTrials.gov registry entry for NCT07523750 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 466 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biosense Webster, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which VARIPULSE Catheter is the first listed.
NCT07523750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07523750 about?
NCT07523750 is a clinical study titled "A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation". The purpose of this study is to assess how safe VARIPULSE pulsed field ablation (PFA) catheter is and how well it works compared to food and drug administration (FDA) approved FARAWAVE PFA catheter in participants with symptomatic persistent atrial fibrillation (PsAF; continuous irregular, rapid hea...
What is the current status of trial NCT07523750?
This trial is currently recruiting. It is a NA study. The enrollment target is 466 participants. The study started on 2026-04-02. Estimated completion is 2028-05-31.
What interventions are being tested in trial NCT07523750?
The interventions under investigation include: VARIPULSE Catheter (DEVICE), FARAWAVE Catheter (DEVICE).
Who is sponsoring clinical trial NCT07523750?
This trial is sponsored by Biosense Webster, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.